From Cancer to Cure
The global scientific research community continues to forge better tools with which to diagnose, treat, and prevent cancer.
Cancer is the world's leading cause of death, followed by heart disease and stroke. There are over 100 known types of cancer affecting the worldwide population. The global scientific research community continues to endeavor to find better ways to diagnose, treat, and prevent these cancers, with the ultimate goal to one day find a cure.
The Academy's scientific teams convene research experts from around the world, often across scientific disciplines, in order to share ideas and collaborate on the latest research findings. Below are some of the upcoming Academy-sponsored conferences and latest publications on cancer research. Topics span environmental contaminants as they relate to cancer, the use of nanotechnology for cancer diagnostics and treatments, the latest in Pancreatic cancer research, as well as how factors such as obesity are contributing to the global cancer epidemic.
May 29–31, 2013 (New York City, USA)
June 11–13, 2013 (Moscow, Russia)
Pancreatic cancer is a leading cause of cancer death in the USA and is poised to become even more significant in coming decades. This cancer usually goes undetected until it has reached advanced stages, and patients face dismal prognoses due to the lack of effective therapies. Expert scientists, translational researchers, and clinical investigators explore multiple promising new approaches to treating this deadly disease.
Advances in medical genetics and human genetics have enabled a more detailed understanding of the impact of genetics in cancer. This volume explores cancer as an individualized problem and addresses the impact of recent advances in cancer biology, genetics, tumor profiling, and medical technology in the personalization of cancer predisposition, diagnosis, prognosis, treatment, and therapy development.
Explore the second generation of emerging therapies and vaccines, as researchers from academia and the biomedical industry discuss new advances in cancer immunology, vaccine development, and recent clinical trials applying different immunomodulatory strategies.
Cancer Metabolomics: Elucidating the Biochemical Programs that Support Cancer Initiation and Progression
The Warburg effect, named after German biochemist, Otto Warburg, defined the field of cancer metabolomics. Otto observed that tumor tissues and normal tissues metabolize glucose differently. These metabolic differences could drive the formation of new cancers or could speed their growth. Explore this eBriefing for the latest in cancer metabolomics research.
You've heard it once; you've heard it a thousand times: the U.S. has a big problem with obesity. But did you know that there are demonstrated links between obesity and all kinds of serious health problems—including cancer? Explore the obesity–cancer connection through this Academy-sponsored podcast.
About the New York Academy of Sciences
The New York Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science, technology, and society worldwide. With 25,000 members in 140 countries, the Academy is creating a global community of science for the benefit of humanity. The Academy's core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large. Please visit us online at www.nyas.org.